Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Pfizer
Explore 473 clinical trials worldwide
Search
Showing 1-50 of 473 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Pfizer
Clinical Trials (473)
NCT06873191
A Study to Learn More About Tukysa Once it is Out in the Korean Market
N/A
Not yet recruiting
600 participants
Started: Dec 1, 2026 · Completed: Jun 30, 2030
2 conditions
1 sponsor
0 locations
NCT06832865
ELISA in Relapsed/Refractory MM
PHASE2
Not yet recruiting
30 participants
Started: Aug 1, 2026 · Completed: Dec 1, 2028
2 conditions
3 sponsors
2 locations
NCT06507904
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
PHASE1
Not yet recruiting
52 participants
Started: Apr 17, 2026 · Completed: Oct 31, 2026
1 condition
1 sponsor
0 locations
NCT06864585
A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan
N/A
Not yet recruiting
59 participants
Started: Mar 15, 2026 · Completed: Mar 30, 2029
1 condition
1 sponsor
0 locations
NCT07123090
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
PHASE2
Not yet recruiting
25 participants
Started: Feb 28, 2026 · Completed: Feb 1, 2028
6 conditions
2 sponsors
2 locations
NCT06983691
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
NA
Not yet recruiting
26 participants
Started: Jan 31, 2026 · Completed: Oct 31, 2026
1 condition
2 sponsors
0 locations
NCT04982848
Korea Post Marketing Surveillance (PMS) Study of Talzenna®
N/A
Not yet recruiting
600 participants
Started: Dec 31, 2025 · Completed: Oct 31, 2026
1 condition
1 sponsor
0 locations
NCT07193394
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
PHASE2
Not yet recruiting
20 participants
Started: Dec 5, 2025 · Completed: Jun 8, 2029
2 conditions
4 sponsors
9 locations
NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
PHASE3
Not yet recruiting
500 participants
Started: Dec 2, 2025 · Completed: Feb 22, 2032
1 condition
1 sponsor
7 locations
NCT07209176
Physician- and Patient-based Barriers to NGS Testing
NA
Not yet recruiting
256 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2026
1 condition
2 sponsors
0 locations
NCT06760208
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
N/A
Not yet recruiting
660 participants
Started: Nov 28, 2025 · Completed: Oct 30, 2028
2 conditions
1 sponsor
1 location
NCT07197762
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
PHASE4
Not yet recruiting
125 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT07216027
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
PHASE2
Not yet recruiting
200 participants
Started: Oct 31, 2025 · Completed: Aug 23, 2027
2 conditions
1 sponsor
0 locations
NCT07174336
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3
Not yet recruiting
920 participants
Started: Oct 31, 2025 · Completed: May 31, 2033
2 conditions
2 sponsors
46 locations
NCT07219615
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
PHASE2
Not yet recruiting
200 participants
Started: Oct 24, 2025 · Completed: Apr 23, 2027
1 condition
1 sponsor
0 locations
NCT07073820
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
PHASE2
Not yet recruiting
36 participants
Started: Oct 24, 2025 · Completed: Jan 8, 2029
1 condition
1 sponsor
0 locations
NCT07206225
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
PHASE1
Not yet recruiting
294 participants
Started: Oct 20, 2025 · Completed: Jan 28, 2033
1 condition
1 sponsor
35 locations
NCT07215078
Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
PHASE1
Not yet recruiting
72 participants
Started: Oct 8, 2025 · Completed: May 7, 2026
1 condition
1 sponsor
1 location
NCT06989437
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
PHASE2/PHASE3
Recruiting
982 participants
Started: Oct 3, 2025 · Completed: Dec 23, 2029
2 conditions
1 sponsor
12 locations
NCT07190430
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
PHASE1
Recruiting
16 participants
Started: Oct 3, 2025 · Completed: Feb 16, 2026
1 condition
1 sponsor
1 location
NCT06899204
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
N/A
Not yet recruiting
150 participants
Started: Oct 1, 2025 · Completed: Sep 30, 2026
3 conditions
1 sponsor
0 locations
NCT07161687
A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.
N/A
Not yet recruiting
50 participants
Started: Sep 30, 2025 · Completed: Dec 13, 2029
1 condition
1 sponsor
0 locations
NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
PHASE2
Not yet recruiting
126 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2029
2 conditions
4 sponsors
2 locations
NCT06521762
Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis
PHASE2
Recruiting
96 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
PHASE3
Recruiting
680 participants
Started: Sep 29, 2025 · Completed: Mar 10, 2032
3 conditions
1 sponsor
6 locations
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
PHASE3
Recruiting
1,000 participants
Started: Sep 28, 2025 · Completed: Dec 8, 2034
4 conditions
1 sponsor
45 locations
NCT07198035
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
PHASE1
Recruiting
12 participants
Started: Sep 18, 2025 · Completed: Dec 26, 2025
1 condition
1 sponsor
1 location
NCT06898047
Consistency of Response With Rimegepant in Acute Treatment of Migraine
N/A
Not yet recruiting
250 participants
Started: Sep 17, 2025 · Completed: May 29, 2026
1 condition
1 sponsor
0 locations
NCT06997081
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
PHASE2
Recruiting
104 participants
Started: Sep 16, 2025 · Completed: Sep 30, 2030
1 condition
2 sponsors
1 location
NCT06103734
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
PHASE3
Not yet recruiting
1,280 participants
Started: Sep 15, 2025 · Completed: Aug 2, 2027
1 condition
1 sponsor
0 locations
NCT07029828
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
PHASE3
Recruiting
140 participants
Started: Sep 10, 2025 · Completed: Jun 26, 2030
1 condition
1 sponsor
4 locations
NCT07160738
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
PHASE1
Not yet recruiting
28 participants
Started: Sep 9, 2025 · Completed: Jan 11, 2026
1 condition
1 sponsor
0 locations
NCT07177209
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
N/A
Not yet recruiting
4,000 participants
Started: Sep 8, 2025 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT07172321
A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
PHASE1
Active, not recruiting
12 participants
Started: Sep 5, 2025 · Completed: Oct 29, 2025
1 condition
1 sponsor
1 location
NCT07152119
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
N/A
Not yet recruiting
3,000 participants
Started: Sep 1, 2025 · Completed: Sep 23, 2030
1 condition
1 sponsor
0 locations
NCT05810727
Atrial Fibrillation Data Linkage Non-Interventional Study
N/A
Not yet recruiting
19,388 participants
Started: Aug 31, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
0 locations
NCT07127770
A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants
PHASE1
Not yet recruiting
9 participants
Started: Aug 28, 2025 · Completed: Nov 5, 2025
1 condition
1 sponsor
1 location
NCT07160244
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
PHASE3
Recruiting
6,000 participants
Started: Aug 25, 2025 · Completed: Mar 2, 2029
1 condition
1 sponsor
23 locations
NCT07090499
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
PHASE1
Recruiting
310 participants
Started: Aug 20, 2025 · Completed: Jul 8, 2029
13 conditions
1 sponsor
2 locations
NCT07089680
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19
N/A
Not yet recruiting
1,200 participants
Started: Aug 18, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
0 locations
NCT07130097
A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants
PHASE1
Not yet recruiting
34 participants
Started: Aug 14, 2025 · Completed: Nov 18, 2025
1 condition
1 sponsor
0 locations
NCT06994897
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
PHASE1
Recruiting
92 participants
Started: Aug 13, 2025 · Completed: Dec 8, 2027
1 condition
1 sponsor
1 location
NCT07122661
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
N/A
Active, not recruiting
1 participants
Started: Aug 11, 2025 · Completed: Apr 30, 2027
5 conditions
2 sponsors
1 location
NCT07122986
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
PHASE1
Recruiting
310 participants
Started: Aug 11, 2025 · Completed: May 25, 2028
1 condition
1 sponsor
10 locations
NCT06974786
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
PHASE2
Recruiting
100 participants
Started: Aug 8, 2025 · Completed: Apr 30, 2033
2 conditions
3 sponsors
3 locations
NCT07153159
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
PHASE1
Recruiting
8 participants
Started: Aug 7, 2025 · Completed: Oct 12, 2026
1 condition
1 sponsor
1 location
NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
PHASE3
Recruiting
400 participants
Started: Aug 5, 2025 · Completed: Nov 4, 2030
1 condition
1 sponsor
8 locations
NCT07086664
A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition
PHASE1
Recruiting
60 participants
Started: Aug 5, 2025 · Completed: Oct 25, 2026
1 condition
1 sponsor
12 locations
NCT06333899
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
EARLY_PHASE1
Active, not recruiting
15 participants
Started: Aug 3, 2025 · Completed: Jun 1, 2035
9 conditions
2 sponsors
17 locations
NCT07029711
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
PHASE3
Recruiting
225 participants
Started: Jul 31, 2025 · Completed: May 18, 2027
1 condition
1 sponsor
17 locations
«
Previous
1
2
3
4
5
6
7
8
9
10
Next